Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis
Open Access
- 17 January 2025
- journal article
- research article
- Published by Wiley in FEBS Open Bio
- Vol. 15 (5) , 754-762
Abstract
Dimethyl fumarate (DMF) is an anti‐inflammatory and immunoregulatory medication used to treat multiple sclerosis (MS) and psoriasis. Its skin sensitization property precludes its topical use, which is unfortunate for the treatment of psoriasis. Isosorbide di‐(methyl fumarate) (IDMF), a novel derivative of DMF, was synthesized to circumvent this adverse reaction and unlock the potential of topical delivery, which could be useful for treating psoriasis in the subpopulation of psoriatic MS patients, as well as in the general population. Here, we compared its therapeutic potential of this non‐sensitizing derivative with DMF and its therapeutic version Diroximel in three skin‐ and neuroinflammation models: the lck‐GFP zebrafish, activated BV‐2 murine microglia and human T‐lymphocyte Jurkat cell line. The results provide a comparative evaluation of the bioactivity of these three related chemical entities in models relevant to skin and neuroinflammation and expose several therapeutic advantages unique to IDMF.Keywords
This publication has 49 references indexed in Scilit:
- Probiotic supplementation improves clinical outcomes and quality of life indicators in patients with plaque psoriasis: A randomized double-blind clinical trialClinical Nutrition ESPEN, 2021
- A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocyte transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotypeBiochemical and Biophysical Research Communications, 2020
- Contributions of T cells in multiple sclerosis: what do we currently know?Journal of Neurology, 2020
- Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 StudyCNS Drugs, 2020
- Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 StudyAdvances in Therapy, 2019
- Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical dataArchives of Dermatological Research, 2018
- RAE-1 expression is induced during experimental autoimmune encephalomyelitis and is correlated with microglia cell proliferationBrain, Behavior, and Immunity, 2016
- The role of IL-17 in CNS diseasesActa Neuropathologica, 2015
- Microglia: Proliferation and activation driven by the P2X7 receptorThe International Journal of Biochemistry & Cell Biology, 2010
- Dexamethasone and 2,3,7,8-tetrachlorodibenzo-p-dioxin can induce thymic atrophy by different mechanisms in miceBiochemical and Biophysical Research Communications, 1991